In the Summer 2017 issue of Viewpoints, research highlights include Dr. Catharine Winstanley’s investigation into the link between dopamine agonists and impulse control issues in Parkinson’s patients. Dr. Winstanley aims to use existing medications like lithium to mitigate these side effects while allowing patients to benefit from dopamine agonists. Additionally, Dr. Beate Ritz discusses how environmental toxins, particularly certain pesticides, may increase the risk of developing Parkinson’s, emphasizing the importance of understanding gene-environment interactions.
The newsletter also features Dr. Roger Barker’s work on stem cell treatments to replace lost dopamine cells, with upcoming trials anticipated. Exercise is underscored as vital for managing Parkinson’s symptoms, highlighting specific programs such as Dance for PD and Rock Steady Boxing. The Society’s advocacy for improved care access is celebrated, including the successful funding of DUODOPA® through BC Pharmacare, which helps individuals with advanced Parkinson’s maintain their independence.
